Your browser doesn't support javascript.
loading
Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver disease.
Mino, Masaaki; Kakazu, Eiji; Sano, Akitoshi; Katsuyama, Hisayuki; Hakoshima, Mariko; Yanai, Hidekatsu; Aoki, Yoshihiko; Imamura, Masatoshi; Yamazoe, Taiji; Mori, Taizo; Yoshio, Sachiyo; Inoue, Jun; Masamune, Atsushi; Kanto, Tatsuya.
Afiliación
  • Mino M; Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
  • Kakazu E; Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
  • Sano A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Katsuyama H; Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hakoshima M; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Yanai H; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
  • Aoki Y; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
  • Imamura M; Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
  • Yamazoe T; Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
  • Mori T; Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan.
  • Yoshio S; Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Inoue J; Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Masamune A; Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kanto T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hepatol Res ; 53(7): 618-628, 2023 Jul.
Article en En | MEDLINE | ID: mdl-36905232
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón